Skip to content
DataLookout
Menu

NCT07690657

Evaluating Intervention Allocation Policies for Reducing Hospital Readmissions at Michigan Medicine

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened Show 4 more changesShow less
    • Eligibility criteria expanded, about 7 words
    • Start date changed from estimate of Jul 2026 to Jul 13, 2026
    • Secondary endpoints: details revised at 5 of 5 entries
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

The number of 30-day all-cause unplanned readmission or death
Timeframe: 30 calendar days following the index discharge

Secondary (5)

The number of 90-day all-cause unplanned readmission or death
Time to first 90-day all-cause unplanned readmission or death
TOC telephone call bundle completion (care navigator call)
TOC telephone call bundle completion (clinical pharmacist call)
TOC telephone call bundle completion (both calls)

Arms and interventions

Control Arm/Standard of careActive comparator

The Control Arm, in which patients with a LACE Index score of 9 or greater on the day of hospital discharge will receive TOC interventions. This is the currently implemented allocation policy at Michigan Medicine. In this setting, approximately 60% of patients receive the TOC intervention. Thus, we will use a threshold of the 40th percentile for assigning the TOC telephone call bundle. Note that to maintain the 60% intervention rate throughout the study, the score threshold (LACE 9 or greater) will be monitored and dynamically adjusted. The LACE Index has four components: Length of Stay (L), Acuity of the Admission (A), Comorbidities (C), and Emergency Department Visits (E), and estimates the risk of a patient having an unplanned hospital readmission after being discharged from their current encounter.

Experimental ArmExperimental

The Experimental Arm, in which Causal-Hospital reAdmission Risk Prediction Model (C-HARP) scores will be used to allocate TOC interventions. C-HARP is a machine learning model that leverages routinely collected and stored patient data in the electronic health record (EHR) to estimate how much a patient will benefit from receiving MM's TOC telephone call bundle. The assignment threshold will be defined as the 40th percentile of C-HARP scores within the most recent 100 days of the target cohort, so that approximately 60% of patients are assigned the telephone call bundle. Based on current retrospective data, this threshold corresponds to a C-HARP score of 18.

Devices: C-HARP TOC assignment

Other: The LACE Index TOC assignment

Sites

1 site in 1 country

  • The University of MichiganAnn Arbor, Michigan, United States